To further validate these results, we assayed MM cell lines treated with fluvastatin and/or bortezomib for Annexin V staining by flow cytometry and ISR activation by qRT-PCR (Fig. 5). The gene discussed is ANXA5; the disease is Miyoshi myopathy.